Cargando…

Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3

SIMPLE SUMMARY: Neoantigens are considered good targets for immunotherapy due to their tumor specificity. However, because neoantigens are unique in individual cancers, it is challenging to select personalized target neoantigens. In this study, we focused on "shared neoantigens", which are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tate, Tomohiro, Matsumoto, Saki, Nemoto, Kensaku, Leisegang, Matthias, Nagayama, Satoshi, Obama, Kazutaka, Nakamura, Yusuke, Kiyotani, Kazuma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953830/ https://www.ncbi.nlm.nih.gov/pubmed/36831375 http://dx.doi.org/10.3390/cancers15041031

Ejemplares similares

Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations
por: Minegishi, Yuriko, et al.
Publicado: (2022)

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19
por: Toyoshima, Yujiro, et al.
Publicado: (2020)

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
por: Kiyotani, Kazuma, et al.
Publicado: (2018)

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
por: Ren, Lili, et al.
Publicado: (2019)

Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy
por: Okamura, Kazumi, et al.
Publicado: (2022)

Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2
por: Kiyotani, Kazuma, et al.
Publicado: (2020)

Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells
por: Kato, Taigo, et al.
Publicado: (2018)

Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma
por: Wei, Teng, et al.
Publicado: (2021)

Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy
por: Nagayama, Satoshi, et al.
Publicado: (2021)

Neoantigens elicit T cell responses in breast cancer
por: Morisaki, Takafumi, et al.
Publicado: (2021)

Mutated genes on ctDNA detecting postoperative recurrence presented reduced neoantigens in primary tumors in colorectal cancer cases
por: Nagayama, Satoshi, et al.
Publicado: (2023)

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
por: Morisaki, Shinji, et al.
Publicado: (2023)

Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors
por: Kiyotani, Kazuma, et al.
Publicado: (2017)

Personalized immunotherapy in cancer precision medicine
por: Kiyotani, Kazuma, et al.
Publicado: (2021)

Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers
por: Kato, Taigo, et al.
Publicado: (2017)

Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy
por: Chan, Hiu Ting, et al.
Publicado: (2020)

Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019)

Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer
por: Zhou, Jie, et al.
Publicado: (2019)

Determinants for Neoantigen Identification
por: Garcia-Garijo, Andrea, et al.
Publicado: (2019)

Identification of non-mutated neoantigens presented by TAP-deficient tumors
por: Marijt, Koen A., et al.
Publicado: (2018)

Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations
por: Iiizumi, Susumu, et al.
Publicado: (2019)

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets
por: Chen, Chao, et al.
Publicado: (2020)

Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?
por: Okamura, Ryosuke, et al.
Publicado: (2023)

Cancer neoantigens and immunogenicity: mutation position matters
por: Capietto, Aude-Hélène, et al.
Publicado: (2020)

Current Trends in Neoantigen-Based Cancer Vaccines
por: Ho, Szu-Ying, et al.
Publicado: (2023)

Main Strategies for the Identification of Neoantigens
por: Gopanenko, Alexander V., et al.
Publicado: (2020)

A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets
por: Zhou, Si, et al.
Publicado: (2022)

Development and evaluation of a colorectal cancer screening method using machine learning‐based gut microbiota analysis
por: Konishi, Yusuke, et al.
Publicado: (2022)

NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021)

Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies
por: Tubb, Vanessa M., et al.
Publicado: (2018)

Mutation position is an important determinant for predicting cancer neoantigens
por: Capietto, Aude-Hélène, et al.
Publicado: (2020)

Lymphoma neoantigens
por: Elias, Joshua E.
Publicado: (2018)

Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy
por: Nagaoka, Koji, et al.
Publicado: (2021)

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
por: Efremova, Mirjana, et al.
Publicado: (2017)

Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors
por: Nakakido, Makoto, et al.
Publicado: (2016)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
por: Okada, Masahiro, et al.
Publicado: (2022)

Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations
por: Miyauchi, Eisaku, et al.
Publicado: (2019)

Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole‐exome sequencing
por: Karasaki, Takahiro, et al.
Publicado: (2017)

CD8 lymphocytes in tumors and nonsynonymous mutational load correlate with prognosis of bladder cancer patients treated with immune checkpoint inhibitors
por: Deng, Boya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_njlgnapo9tgfqbojguthquslgm